Is it time for in HR-MDS?

In recognition of Blood Cancer Awareness Month, Gilead is continuing to investigate if there is more of the immune system left to unlock.

See what new research is emerging

Actor portrayal.

This information is intended for US healthcare professionals.

Brought to you by

Actor Portrayal

ADVANCING TREATMENTS FOR HIGHER-RISK MDS HAS REMAINED AN UNSOLVED MYSTERY FOR FAR TOO LONG

New targets continue to emerge that have the potential to break the case against MDS wide open.

Could investigating the innate immune system lead to clues about innovation?

Investigate Further

Actor portrayal.

Watch NEW developments in the ONGOING case against higher-risk MDS

Get Updates

Investigate clues about
the immune system

MDS and the
Immune System

Reveal the need for
more effective
first-line
treatments

Taking on
Higher-Risk MDS

MDS, myelodysplastic syndrome.